glioblastoma News

Trial Involves a New Brain Cancer Vaccine, Tailored to a Patient's Own Tumor

Northwest Biotherapeutics, a leading biotechnology company, is seeking to enroll over 240 brain cancer patients in a major clinical trial for DCVax®, a life-saving vaccine for brain cancer

Glioblastoma patient using experimental vaccine consisting of his own brain tumor tissue and white blood cells

Blogging in B Minor (markmillermusic.org/blog) chronicles Mark Miller's journey as a grade 4 brain tumor survivor and provides other brain tumor survivors with in-depth research information and personal experience to provide hope and encouragement.